DR. BRENDA L PLANCK M.D.
Prescription History 1417929068
Psychiatry & Neurology - Forensic Psychiatry in Middletown, CT

NPI Status: Active since February 07, 2006

Contact Information

O'BRIEN DRIVE
MIDDLETOWN, CT
ZIP 06457
Phone: (860) 262-5486

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. BRENDA L PLANCK M.D., an active Forensic Psychiatry specialist practicing in Middletown, CT. Our medical registry currently tracks 49 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,284 documented patient claims. Among these therapy options, the most frequently utilized medication is Clozapine, which accounts for 240 claims alone.


Abilify Maintena

Generic Formulation: AripiprazoleSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 20
30-Day Fills 20.0
Days Supply 443
CT State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills22.1
Peer Average Days Supply621
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $55,032.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,751.63

State Avg Cost Per Claim

$2,697.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A piperazine and quinolone derivative that is used primarily as an antipsychotic agent. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as an adjunct therapy for the treatment of depression.

Therapeutic Applications

Aripiprazole is used to treat certain mental/mood disorders (such as bipolar disorder, schizophrenia, Tourette's syndrome, and irritability associated with autistic disorder). It may also be used in combination with other medication to treat depression. Aripiprazole is known as an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural chemicals in the brain (neurotransmitters). This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. Aripiprazole can treat severe mood swings and decrease how often mood swings occur.

Aripiprazole

Generic Formulation: AripiprazoleSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 61
30-Day Fills 67.0
Days Supply 1,920
CT State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills61.8
Peer Average Days Supply1,788
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 38.6% more claims than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,162.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$133.81

State Avg Cost Per Claim

$154.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A piperazine and quinolone derivative that is used primarily as an antipsychotic agent. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as an adjunct therapy for the treatment of depression.

Therapeutic Applications

Aripiprazole is used to treat certain mental/mood disorders (such as bipolar disorder, schizophrenia, Tourette's syndrome, and irritability associated with autistic disorder). It may also be used in combination with other medication to treat depression. Aripiprazole is known as an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural chemicals in the brain (neurotransmitters). This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. Aripiprazole can treat severe mood swings and decrease how often mood swings occur.

Benztropine Mesylate

Generic Formulation: Benztropine MesylateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 76
30-Day Fills 82.0
Days Supply 2,328
CT State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills59.7
Peer Average Days Supply1,686
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 49.0% more claims than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $841.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.08

State Avg Cost Per Claim

$14.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.

Therapeutic Applications

Benztropine is used to treat symptoms of Parkinson's disease or involuntary movements due to the side effects of certain psychiatric drugs (antipsychotics such as chlorpromazine/haloperidol). Benztropine belongs to a class of medication called anticholinergics that work by blocking a certain natural substance (acetylcholine). This helps decrease muscle stiffness, sweating, and the production of saliva, and helps improve walking ability in people with Parkinson's disease. Anticholinergics can stop severe muscle spasms of the back, neck, and eyes that are sometimes caused by psychiatric drugs. It can also decrease other side effects such as muscle stiffness/rigidity (extrapyramidal signs-EPS). It is not helpful in treating movement problems caused by tardive dyskinesia and may worsen them. Benztropine should not be used by children younger than 3 years.

Bupropion Hcl

Generic Formulation: Bupropion HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 12
30-Day Fills 14.0
Days Supply 398
CT State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills27.1
Peer Average Days Supply779
Conservative Utilization

This provider writes prescriptions for this formulation 36.8% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $206.09 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.17

State Avg Cost Per Claim

$27.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Bupropion is used to treat depression. It can improve your mood and feelings of well-being. It may work by helping to restore the balance of certain natural chemicals (neurotransmitters) in your brain.

Bupropion Xl

Generic Formulation: Bupropion HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 32
30-Day Fills 32.0
Days Supply 934
CT State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills77.2
Peer Average Days Supply2,288
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $418.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.06

State Avg Cost Per Claim

$43.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Bupropion is used to treat depression. It can improve your mood and feelings of well-being. It may work by helping to restore the balance of certain natural chemicals (neurotransmitters) in your brain.

Buspirone Hcl

Generic Formulation: Buspirone HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 22
30-Day Fills 29.0
Days Supply 846
CT State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills52.8
Peer Average Days Supply1,522
Conservative Utilization

This provider writes prescriptions for this formulation 38.9% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $472.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.46

State Avg Cost Per Claim

$23.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat anxiety. It may help you think more clearly, relax, worry less, and take part in everyday life. It may also help you to feel less jittery and irritable, and may control symptoms such as trouble sleeping, sweating, and pounding heartbeat. Buspirone is a medication for anxiety (anxiolytic) that works by affecting certain natural substances in the brain (neurotransmitters).

Carbamazepine

Generic Formulation: CarbamazepineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 20
30-Day Fills 36.0
Days Supply 1,056
CT State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills30.4
Peer Average Days Supply872
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,834.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$91.74

State Avg Cost Per Claim

$78.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.

Therapeutic Applications

Carbamazepine is used to prevent and control seizures. This medication is known as an anticonvulsant or anti-epileptic drug. It is also used to relieve certain types of nerve pain (such as trigeminal neuralgia). This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity.

Carbamazepine Er

Generic Formulation: CarbamazepineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 52
30-Day Fills 52.0
Days Supply 1,456
CT State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills35.1
Peer Average Days Supply1,017
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 126.1% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,790.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$72.90

State Avg Cost Per Claim

$183.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.

Therapeutic Applications

Carbamazepine is used to prevent and control seizures. This medication is known as an anticonvulsant or anti-epileptic drug. It is also used to relieve certain types of nerve pain (such as trigeminal neuralgia). This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity.

Chlorpromazine Hcl

Generic Formulation: Chlorpromazine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 35
30-Day Fills 35.0
Days Supply 736
CT State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills27.9
Peer Average Days Supply785
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 40.0% more claims than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,900.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$140.00

State Avg Cost Per Claim

$364.31

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.

Therapeutic Applications

This medication is used to treat certain mental/mood disorders (such as schizophrenia, psychotic disorders, manic phase of bipolar disorder, severe behavioral problems in children). Chlorpromazine helps you to think more clearly, feel less nervous, and take part in everyday life. It can reduce aggressive behavior and the desire to hurt yourself/others. It may also help to decrease hallucinations (hearing/seeing things that are not there). Chlorpromazine is a psychiatric medication that belongs to the class of drugs called phenothiazine antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. Chlorpromazine is also used to control nausea/vomiting, relieve prolonged hiccups, relieve restlessness/anxiety before surgery, and help treat tetanus.

Clonazepam

Generic Formulation: ClonazepamSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 113
30-Day Fills 113.0
Days Supply 2,792
CT State Average Benchmarks
Peer Average Claims52.0
Peer Average 30-Day Fills59.8
Peer Average Days Supply1,693
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 117.3% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $871.60 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.71

State Avg Cost Per Claim

$10.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.

Therapeutic Applications

Clonazepam is used to prevent and control seizures. This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines.

Clozapine

Generic Formulation: ClozapineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 240
30-Day Fills 240.0
Days Supply 6,689
CT State Average Benchmarks
Peer Average Claims63.0
Peer Average 30-Day Fills64.1
Peer Average Days Supply1,548
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 281.0% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $18,125.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$75.52

State Avg Cost Per Claim

$79.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.

Therapeutic Applications

See also Warning section. This medication is used to treat certain mental/mood disorders (schizophrenia, schizoaffective disorders). Clozapine is a psychiatric medication (anti-psychotic type) that works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain. Clozapine decreases hallucinations and helps prevent suicide in people who are likely to try to harm themselves. It helps you to think more clearly and positively about yourself, feel less nervous, and take part in everyday life.

Desmopressin Acetate

Generic Formulation: Desmopressin AcetateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 364
CT State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills26.3
Peer Average Days Supply753
Conservative Utilization

This provider writes prescriptions for this formulation 27.8% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $588.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$45.27

State Avg Cost Per Claim

$110.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.

Therapeutic Applications

Desmopressin is used to control the amount of urine your kidneys make. Normally, the amount of urine you make is controlled by a certain substance in the body called vasopressin. In people who have water diabetes (diabetes insipidus) or certain kinds of head injury or brain surgery, the body does not make enough vasopressin. Desmopressin is a man-made form of vasopressin and is used to replace a low level of vasopressin. This medication helps to control increased thirst and too much urination due to these conditions, and helps prevent dehydration. Desmopressin is also used to control bleeding caused by surgery or injuries in people with certain bleeding problems (hemophilia A, type 1 von Willebrand's disease). It works by helping the body with normal blood clotting.

Desvenlafaxine Succinate Er

Generic Formulation: Desvenlafaxine SuccinateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 396
CT State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills42.9
Peer Average Days Supply1,248
Conservative Utilization

This provider writes prescriptions for this formulation 48.1% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,241.43 across this reporting matrix range.

Provider Avg Cost Per Claim

$88.67

State Avg Cost Per Claim

$122.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.

Therapeutic Applications

Desvenlafaxine is used to treat depression. It may improve your mood, feelings of well-being, and energy level. Desvenlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Diazepam

Generic Formulation: DiazepamSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 365
CT State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills29.2
Peer Average Days Supply693
Conservative Utilization

This provider writes prescriptions for this formulation 46.2% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $69.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.00

State Avg Cost Per Claim

$7.35

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.

Therapeutic Applications

This medication is used to treat episodes of increased seizures (such as cluster or breakthrough seizures) in people who are already taking medications to control their seizures. This product is only recommended for short-term treatment of seizure attacks. It is not for ongoing daily use to prevent seizures. Uncontrolled seizures can turn into serious (possibly fatal) seizures that do not stop (status epilepticus). This medication is not recommended for children younger than 6 months of age because of the risk of serious side effects. Diazepam works by calming the brain and nerves. It belongs to a class of drugs known as benzodiazepines.

Divalproex Sodium

Generic Formulation: Divalproex SodiumSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 532
CT State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills52.9
Peer Average Days Supply1,468
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.7% less volume than the regional standard for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $991.01 across this reporting matrix range.

Provider Avg Cost Per Claim

$52.16

State Avg Cost Per Claim

$64.71

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.

Therapeutic Applications

This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Divalproex Sodium Er

Generic Formulation: Divalproex SodiumSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 117
30-Day Fills 117.0
Days Supply 3,302
CT State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills46.2
Peer Average Days Supply1,318
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 216.2% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,697.44 across this reporting matrix range.

Provider Avg Cost Per Claim

$99.98

State Avg Cost Per Claim

$99.47

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.

Therapeutic Applications

This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Duloxetine Hcl

Generic Formulation: Duloxetine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 24
30-Day Fills 24.0
Days Supply 636
CT State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills79.4
Peer Average Days Supply2,333
Conservative Utilization

This provider writes prescriptions for this formulation 44.2% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $556.79 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.20

State Avg Cost Per Claim

$54.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.

Therapeutic Applications

Duloxetine is used to treat depression and anxiety. In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Escitalopram Oxalate

Generic Formulation: Escitalopram OxalateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 76
30-Day Fills 94.0
Days Supply 2,774
CT State Average Benchmarks
Peer Average Claims64.0
Peer Average 30-Day Fills122.1
Peer Average Days Supply3,583
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,092.79 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.38

State Avg Cost Per Claim

$17.97

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder.

Therapeutic Applications

Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI). It may improve your energy level and feelings of well-being and decrease nervousness.

Fluoxetine Hcl

Generic Formulation: Fluoxetine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 68
30-Day Fills 74.0
Days Supply 2,164
CT State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills66.7
Peer Average Days Supply1,970
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 94.3% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $768.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.31

State Avg Cost Per Claim

$17.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.

Therapeutic Applications

This long-acting form of fluoxetine is used to treat depression in people who have been successfully treated with the form of fluoxetine that is taken daily. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI). SSRIs work by helping to restore the balance of certain natural substances in the brain (neurotransmitters such as serotonin). Fluoxetine may decrease anxiety, improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living.

Fluvoxamine Maleate

Generic Formulation: Fluvoxamine MaleateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 30
30-Day Fills 38.0
Days Supply 1,116
CT State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills32.6
Peer Average Days Supply891
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,307.53 across this reporting matrix range.

Provider Avg Cost Per Claim

$76.92

State Avg Cost Per Claim

$52.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS.

Therapeutic Applications

Fluvoxamine is used to treat obsessive-compulsive disorder (OCD). It helps decrease thoughts that are unwanted or that don't go away (obsessions), and it helps to reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, checking) that interfere with daily living. Fluvoxamine is known as a selective serotonin reuptake inhibitor (SSRI). This medication works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Gabapentin

Generic Formulation: GabapentinSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 46
30-Day Fills 54.0
Days Supply 1,602
CT State Average Benchmarks
Peer Average Claims70.0
Peer Average 30-Day Fills105.6
Peer Average Days Supply3,058
Conservative Utilization

This provider writes prescriptions for this formulation 34.3% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $543.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.81

State Avg Cost Per Claim

$23.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Glycopyrrolate

Generic Formulation: GlycopyrrolateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 364
CT State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills20.6
Peer Average Days Supply552
Conservative Utilization

This provider writes prescriptions for this formulation 31.6% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $236.55 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.20

State Avg Cost Per Claim

$32.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics.

Therapeutic Applications

Glycopyrrolate solution is used to reduce excessive drooling caused by medical conditions (such as cerebral palsy). This medication works by decreasing the amount of saliva you make. Glycopyrrolate belongs to a class of drugs known as anticholinergics.

Haloperidol

Generic Formulation: HaloperidolSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 42
30-Day Fills 42.0
Days Supply 1,153
CT State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills35.5
Peer Average Days Supply992
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 31.3% more claims than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,759.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$41.89

State Avg Cost Per Claim

$40.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)

Therapeutic Applications

Haloperidol is used to treat certain mental/mood disorders (such as schizophrenia, schizoaffective disorders). This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can also help prevent suicide in people who are likely to harm themselves. It also reduces aggression and the desire to hurt others. It can decrease negative thoughts and hallucinations. Haloperidol can also be used to treat uncontrolled movements and outbursts of words/sounds related to Tourette's syndrome. Haloperidol is also used for severe behavior problems in hyperactive children when other treatments or medications have not worked. Haloperidol is a psychiatric medication (antipsychotic-type) that works by helping to restore the balance of certain natural substances in the brain (neurotransmitters).

Hydroxyzine Hcl

Generic Formulation: Hydroxyzine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 24
30-Day Fills 24.0
Days Supply 457
CT State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills34.3
Peer Average Days Supply890
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $363.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.13

State Avg Cost Per Claim

$22.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Hydroxyzine is used to treat itching caused by allergies. It is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Hydroxyzine may also be used short-term to treat anxiety or to help you feel sleepy/relaxed before and after surgery.

Hydroxyzine Pamoate

Generic Formulation: Hydroxyzine PamoateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 23
30-Day Fills 33.0
Days Supply 974
CT State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills36.0
Peer Average Days Supply977
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $271.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.80

State Avg Cost Per Claim

$14.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.

Therapeutic Applications

Hydroxyzine is used to treat itching caused by allergies. It is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Hydroxyzine may also be used short-term to treat anxiety or to help you feel sleepy/relaxed before and after surgery.

Ingrezza

Generic Formulation: Valbenazine TosylateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 416
CT State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills20.3
Peer Average Days Supply576
Conservative Utilization

This provider writes prescriptions for this formulation 26.3% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $115,297.87 across this reporting matrix range.

Provider Avg Cost Per Claim

$8,235.56

State Avg Cost Per Claim

$7,739.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Valbenazine is used to treat involuntary movements of the face, tongue, or other body parts (tardive dyskinesia). This medication is thought to work by decreasing the amount of certain natural substances in the brain that affect how your nerves and muscles work (monoamines such as dopamine, serotonin, and norepinephrine).

Invega Sustenna

Generic Formulation: Paliperidone PalmitateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 23
30-Day Fills 23.0
Days Supply 644
CT State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills28.3
Peer Average Days Supply784
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $57,264.64 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,489.77

State Avg Cost Per Claim

$2,597.09

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.

Therapeutic Applications

Paliperidone is used to treat a certain mental/mood disorder called schizophrenia. This medication can decrease hallucinations, help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Paliperidone is an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain. This long-acting form of paliperidone is used only after you have received treatment with either the monthly injectable form of this drug for at least 4 months, or the every-3-month injectable form for at least 3 months.

Lamotrigine

Generic Formulation: LamotrigineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 27
30-Day Fills 35.0
Days Supply 1,004
CT State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills74.0
Peer Average Days Supply2,156
Conservative Utilization

This provider writes prescriptions for this formulation 42.6% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $495.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.34

State Avg Cost Per Claim

$16.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.

Therapeutic Applications

Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

Lithium Carbonate

Generic Formulation: Lithium CarbonateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 25
30-Day Fills 25.0
Days Supply 692
CT State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills34.7
Peer Average Days Supply971
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $273.64 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.95

State Avg Cost Per Claim

$9.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.

Therapeutic Applications

This medication is used to treat manic-depressive disorder (bipolar disorder). It works to stabilize the mood and reduce extremes in behavior by restoring the balance of certain natural substances (neurotransmitters) in the brain. Some of the benefits of continued use of this medication include decreasing how often manic episodes occur and decreasing the symptoms of manic episodes, such as exaggerated feelings of well-being, feelings that others wish to harm you, irritability, anxiousness, rapid/loud speech, and aggressive/hostile behaviors.

Lithium Carbonate Er

Generic Formulation: Lithium CarbonateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 37
30-Day Fills 39.0
Days Supply 1,118
CT State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills32.6
Peer Average Days Supply944
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 54.2% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,163.42 across this reporting matrix range.

Provider Avg Cost Per Claim

$31.44

State Avg Cost Per Claim

$18.28

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.

Therapeutic Applications

This medication is used to treat manic-depressive disorder (bipolar disorder). It works to stabilize the mood and reduce extremes in behavior by restoring the balance of certain natural substances (neurotransmitters) in the brain. Some of the benefits of continued use of this medication include decreasing how often manic episodes occur and decreasing the symptoms of manic episodes, such as exaggerated feelings of well-being, feelings that others wish to harm you, irritability, anxiousness, rapid/loud speech, and aggressive/hostile behaviors.

Lorazepam

Generic Formulation: LorazepamSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 38
30-Day Fills 38.0
Days Supply 848
CT State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills53.2
Peer Average Days Supply1,381
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $306.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.06

State Avg Cost Per Claim

$8.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Therapeutic Applications

This medication is used to treat serious seizures that do not stop (status epilepticus). It is also used before surgeries or procedures to cause drowsiness, decrease anxiety, and cause forgetfulness about the procedure or surgery. Lorazepam belongs to a class of medications called benzodiazepines, which produce a calming effect on the brain and nerves (central nervous system). It is thought to work by increasing the effect of a certain natural chemical (GABA) in the brain.

Lurasidone Hcl

Generic Formulation: Lurasidone HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 310
CT State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$435.15

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Metformin Hcl

Generic Formulation: Metformin HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 11
30-Day Fills 13.0
Days Supply 390
CT State Average Benchmarks
Peer Average Claims82.0
Peer Average 30-Day Fills199.2
Peer Average Days Supply5,920
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 86.6% less volume than the regional standard for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $17.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$1.63

State Avg Cost Per Claim

$9.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Mirtazapine

Generic Formulation: MirtazapineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 58
30-Day Fills 60.0
Days Supply 1,720
CT State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills71.1
Peer Average Days Supply2,021
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,449.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.99

State Avg Cost Per Claim

$27.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Therapeutic Applications

Mirtazapine is used to treat depression. It improves mood and feelings of well-being. Mirtazapine is an antidepressant that works by restoring the balance of natural chemicals (neurotransmitters) in the brain.

Olanzapine

Generic Formulation: OlanzapineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 220
30-Day Fills 228.0
Days Supply 6,465
CT State Average Benchmarks
Peer Average Claims50.0
Peer Average 30-Day Fills61.3
Peer Average Days Supply1,736
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 340.0% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,718.46 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.45

State Avg Cost Per Claim

$41.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy.

Therapeutic Applications

Olanzapine is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder). It may also be used in combination with other medication to treat depression. This medication can help to decrease hallucinations and help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Olanzapine belongs to a class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. Talk to the doctor about the risks and benefits of treatment (especially when used by teenagers). See also Precautions section.

Olanzapine Odt

Generic Formulation: OlanzapineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 56
30-Day Fills 61.2
Days Supply 1,708
CT State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills24.7
Peer Average Days Supply710
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 143.5% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $15,489.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$276.60

State Avg Cost Per Claim

$162.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy.

Therapeutic Applications

Olanzapine is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder). It may also be used in combination with other medication to treat depression. This medication can help to decrease hallucinations and help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Olanzapine belongs to a class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. Talk to the doctor about the risks and benefits of treatment (especially when used by teenagers). See also Precautions section.

Paliperidone Er

Generic Formulation: PaliperidoneSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 336
CT State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills29.5
Peer Average Days Supply826
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 53.8% less volume than the regional standard for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $12,393.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,032.82

State Avg Cost Per Claim

$458.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.

Therapeutic Applications

This medication is used to treat certain mental/mood disorders (such as schizophrenia, schizoaffective disorder). This medication can decrease hallucinations and help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Paliperidone belongs to a class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.

Paroxetine Hcl

Generic Formulation: Paroxetine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 42
30-Day Fills 48.0
Days Supply 1,364
CT State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills50.6
Peer Average Days Supply1,494
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 61.5% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $580.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.83

State Avg Cost Per Claim

$17.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Paroxetine is used to treat depression, panic attacks, anxiety disorders, and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Paroxetine is known as a selective serotonin reuptake inhibitor (SSRI). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. Paroxetine may lessen premenstrual symptoms such as irritability, increased appetite, and depression.

Perphenazine

Generic Formulation: PerphenazineSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 30
30-Day Fills 30.0
Days Supply 842
CT State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills34.6
Peer Average Days Supply989
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,206.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$106.88

State Avg Cost Per Claim

$82.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE.

Therapeutic Applications

This medication is used to treat certain mental/mood disorders (such as schizophrenia, manic phase of bipolar disorder, schizoaffective disorder). This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can reduce aggressive behavior and the desire to hurt yourself/others. It may also help to decrease hallucinations (such as hearing/seeing things that are not there). Perphenazine is a psychiatric medication (antipsychotic-type) that works by helping to restore the balance of certain natural substances (such as dopamine) in the brain.

Prazosin Hcl

Generic Formulation: Prazosin HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 388
CT State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills42.0
Peer Average Days Supply1,207
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.1% less volume than the regional standard for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $862.37 across this reporting matrix range.

Provider Avg Cost Per Claim

$66.34

State Avg Cost Per Claim

$35.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.

Therapeutic Applications

Prazosin is used with or without other medications to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Prazosin belongs to a class of medications called alpha blockers. It works by relaxing and widening blood vessels so blood can flow more easily.

Propranolol Hcl

Generic Formulation: Propranolol HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 51
30-Day Fills 57.0
Days Supply 1,602
CT State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills38.5
Peer Average Days Supply1,117
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 121.7% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $789.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.49

State Avg Cost Per Claim

$28.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This formulation of propranolol is used for infants and children to treat a certain benign tumor (proliferating infantile hemangioma). It helps to shrink the tumor. Propranolol belongs to a class of drugs known as beta blockers.

Propranolol Hcl Er

Generic Formulation: Propranolol HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 23
30-Day Fills 25.0
Days Supply 724
CT State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills39.6
Peer Average Days Supply1,168
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $587.67 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.55

State Avg Cost Per Claim

$87.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This formulation of propranolol is used for infants and children to treat a certain benign tumor (proliferating infantile hemangioma). It helps to shrink the tumor. Propranolol belongs to a class of drugs known as beta blockers.

Quetiapine Fumarate

Generic Formulation: Quetiapine FumarateSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 93
30-Day Fills 99.0
Days Supply 2,500
CT State Average Benchmarks
Peer Average Claims57.0
Peer Average 30-Day Fills75.5
Peer Average Days Supply2,132
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 63.2% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,563.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$27.56

State Avg Cost Per Claim

$35.68

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER.

Therapeutic Applications

This medication is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder, sudden episodes of mania or depression associated with bipolar disorder). Quetiapine is known as an anti-psychotic drug (atypical type). It works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain. This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. It may also improve your mood, sleep, appetite, and energy level. Quetiapine can help prevent severe mood swings or decrease how often mood swings occur.

Riluzole

Generic Formulation: RiluzoleSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 364
CT State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills26.9
Peer Average Days Supply734
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,757.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$135.23

State Avg Cost Per Claim

$313.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Therapeutic Applications

This medication is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called Lou Gehrig's disease). Riluzole helps to slow down the worsening of this disease and prolong survival.

Risperdal Consta

Generic Formulation: Risperidone MicrospheresSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 50
30-Day Fills 50.0
Days Supply 1,403
CT State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills26.4
Peer Average Days Supply529
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 92.3% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $123,887.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,477.76

State Avg Cost Per Claim

$1,391.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.

Therapeutic Applications

Risperidone is used to treat certain mental/mood disorders (schizophrenia, bipolar disorder). This medication can help you to think clearly and take part in everyday life. Risperidone belongs to a class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.

Risperidone

Generic Formulation: RisperidoneSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 68
30-Day Fills 74.0
Days Supply 2,101
CT State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills61.8
Peer Average Days Supply1,743
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 33.3% more claims than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $708.41 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.42

State Avg Cost Per Claim

$15.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.

Therapeutic Applications

Risperidone is used to treat a certain mental/mood disorder called schizophrenia. This medication can decrease hallucinations, help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Risperidone is an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural substances in the brain.

Trazodone Hcl

Generic Formulation: Trazodone HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 117
30-Day Fills 123.0
Days Supply 3,497
CT State Average Benchmarks
Peer Average Claims73.0
Peer Average 30-Day Fills109.1
Peer Average Days Supply3,071
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 60.3% higher than the standard regional baseline profile for CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,024.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.75

State Avg Cost Per Claim

$13.38

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat depression. It may help to improve your mood, appetite, and energy level as well as decrease anxiety and insomnia related to depression. Trazodone works by helping to restore the balance of a certain natural chemical (serotonin) in the brain.

Venlafaxine Hcl Er

Generic Formulation: Venlafaxine HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 19
30-Day Fills 29.0
Days Supply 842
CT State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills61.6
Peer Average Days Supply1,807
Conservative Utilization

This provider writes prescriptions for this formulation 44.1% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $512.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.95

State Avg Cost Per Claim

$35.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Venlafaxine is used to treat depression, anxiety, panic attacks, and social anxiety disorder (social phobia). It may improve your mood and energy level and may help restore your interest in daily living. It may also decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. Venlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Ziprasidone Hcl

Generic Formulation: Ziprasidone HclSpecialty: Psychiatry
Provider Metrics Summary
Total Claims 27
30-Day Fills 33.0
Days Supply 990
CT State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills32.1
Peer Average Days Supply909
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,996.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$73.94

State Avg Cost Per Claim

$104.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain mental/mood disorders (schizophrenia, bipolar disorder). This medication can decrease hallucinations and help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Ziprasidone belongs to a class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. BRENDA L PLANCK M.D. provides transparency into local medical care patterns within Middletown, CT.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Forensic Psychiatry** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.